Citation 105955

CIMANGA,K: DE BRUYNE,T: PIETERS,L: TOTTE,J: TONA,L: KAMBU,K: BERGHE,DV: VLIETINCK,AJ:. (1998). ANTIBACTERIAL AND ANTIFUNGAL ACTIVITIES OF NEOCRYPTOLEPINE, BISCRYTOLEPINE AND CRYPTOQUINDOLINE, ALKALOIDS ISOLATED FROM CRYPTOLEPIS SANGUINOLENTA.. 5(3)

Citation Details

Title	ANTIBACTERIAL AND ANTIFUNGAL ACTIVITIES OF NEOCRYPTOLEPINE, BISCRYTOLEPINE AND CRYPTOQUINDOLINE, ALKALOIDS ISOLATED FROM CRYPTOLEPIS SANGUINOLENTA.
Authors	CIMANGA,K: DE BRUYNE,T: PIETERS,L: TOTTE,J: TONA,L: KAMBU,K: BERGHE,DV: VLIETINCK,AJ:
Year	1998
Volume	5
Issue	3

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Cryptolepis sanguinolenta (ASCLEPIADACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CRYPTOLEPINE,NEO:	None
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	WEAK ACTIVITY
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	WEAK ACTIVITY
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	ACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	INACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	INACTIVE
8	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	INACTIVE
9	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	WEAK ACTIVITY
10	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	INACTIVE
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	INACTIVE
12	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	WEAK ACTIVITY
13	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	INACTIVE
14	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	INACTIVE
15	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	INACTIVE
16	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,NEO:	INACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CRYPTOLEPINE,BIS:	None
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	WEAK ACTIVITY
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	ACTIVE
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
21	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	WEAK ACTIVITY
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
25	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
27	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
28	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
29	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
30	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
31	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
32	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,BIS:	INACTIVE
33	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CRYPTOQUINDOLINE	None
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
35	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
37	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
38	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
39	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
40	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
41	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
42	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
43	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
44	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
45	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
46	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
47	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE
48	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOQUINDOLINE	INACTIVE

Citation 105955

Citation Details

Summary

Organisms and Their Experiments (1)

Cryptolepis sanguinolenta (ASCLEPIADACEAE)

Show SPARQL Queries (1)

Query 1